BIAF — BIOAFFINITY TECHNOLOGIES INC
As of Q2 2026, 5 SEC-registered investment managers reported holding BIAF (BIOAFFINITY TECHNOLOGIES INC) in their latest 13F filings, with a combined reported value of $138.61K across 170.70K shares. That is +142.8% by share count (+100.41K shares) versus the previous quarter, while reported value moved -48.5%. Ownership is concentrated: the five largest holders account for 100.0% of reported value and the top ten for 100.0%.
Compared with the prior quarter, 1 opened new positions, 2 added to existing stakes, 1 trimmed, 1 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
BIAF is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Q2 2026 — 5 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| BlackRock Inc history | 98.78K | $80.21K | 0.00% | New |
| Geode Capital Management history | 50.97K | $41.38K | 0.00% | Add |
| Northern Trust Corp history | 16.75K | $13.60K | 0.00% | Add |
| UBS Group AG history | 4.20K | $3.41K | 0.00% | Reduce |
| Morgan Stanley history | 3 | $2 | 0.00% | Hold |
Q1 2026 — 5 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| Geode Capital Management history | 48.29K | $184.96K | 0.00% | Add |
| Northern Trust Corp history | 12.72K | $48.74K | 0.00% | Hold |
| UBS Group AG history | 9.21K | $35.29K | 0.00% | New |
| Citigroup Inc history | 57 | $218 | 0.00% | Reduce |
| Morgan Stanley history | 3 | $11 | 0.00% | Hold |
Q4 2025 — 6 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| Geode Capital Management history | 30.42K | $35.90K | 0.00% | New |
| Northern Trust Corp history | 12.72K | $15.02K | 0.00% | New |
| Citadel Advisors history | 11.63K | $13.72K | 0.00% | New |
| Citigroup Inc history | 7.74K | $9.13K | 0.00% | Add |
| Bank of America Corp history | 38 | $45 | 0.00% | Reduce |
| Morgan Stanley history | 3 | $4 | 0.00% | Hold |
Q3 2025 — 6 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| Vanguard Group history | 10.43K | $30.87K | 0.00% | Reduce |
| Bank of America Corp history | 1.68K | $4.99K | 0.00% | Add |
| UBS Group AG history | 143 | $423 | 0.00% | Add |
| Citigroup Inc history | 75 | $222 | 0.00% | Reduce |
| Fidelity Management & Research (FMR) history | 26 | $77 | 0.00% | New |
| Morgan Stanley history | 3 | $9 | 0.00% | Reduce |
Q2 2025 — 8 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| Geode Capital Management history | 125.46K | $36.03K | 0.00% | Add |
| Vanguard Group history | 40.64K | $11.66K | 0.00% | Reduce |
| Northern Trust Corp history | 13.66K | $3.92K | 0.00% | Hold |
| Citigroup Inc history | 1.48K | $424 | 0.00% | New |
| Bank of America Corp history | 205 | $58 | 0.00% | Add |
| Morgan Stanley history | 100 | $29 | 0.00% | Reduce |
| Morgan Stanley history | 100 | $29 | 0.00% | Reduce |
| UBS Group AG history | 24 | $7 | 0.00% | New |
Q1 2025 — 8 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| Vanguard Group history | 176.90K | $45.99K | 0.00% | Reduce |
| Geode Capital Management history | 118.69K | $30.86K | 0.00% | Add |
| Northern Trust Corp history | 13.66K | $3.55K | 0.00% | Hold |
| Morgan Stanley history | 300 | $78 | 0.00% | Reduce |
| Morgan Stanley history | 300 | $78 | 0.00% | Reduce |
| Bank of America Corp history | 88 | $23 | 0.00% | Add |
| JPMorgan Chase & Co history | 18 | $5 | 0.00% | Reduce |
| JPMorgan Chase & Co history | 18 | $5 | 0.00% | Reduce |
New Positions (Q2 2026)
- BlackRock Inc 98.78K sh · $80.21K
Fully Exited (vs previous quarter)
- Citigroup Inc sold 57 sh · $218
Fund Position History — shares by quarter (top 14 funds)
| Fund | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BlackRock Inc | 98.78K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Geode Capital Management | 50.97K | 48.29K | 30.42K | — | 125.46K | 118.69K | 99.55K | 87.18K | 69.60K | 42.08K | 36.77K | — | — | — | — | — |
| Northern Trust Corp | 16.75K | 12.72K | 12.72K | — | 13.66K | 13.66K | 13.66K | 13.66K | 13.66K | 13.66K | — | — | — | — | — | — |
| UBS Group AG | 4.20K | 9.21K | — | 143 | 24 | — | — | — | 9.59K | — | — | 65 | 95 | 2.41K | 6.58K | 4.92K |
| Morgan Stanley | 3 | 3 | 3 | 3 | 100 | 300 | 500 | 4.96K | 1.00K | — | — | — | — | — | 3 | — |
| Citadel Advisors | — | — | 11.63K | — | — | — | 13.26K | — | — | — | — | — | — | — | — | 20.58K |
| Fidelity Management & Research (FMR) | — | — | — | 26 | — | — | — | — | — | — | — | — | — | — | — | — |
| JPMorgan Chase & Co | — | — | — | — | — | 18 | 21 | 21 | 18 | 13 | 9 | 7 | — | — | — | — |
| Bank of America Corp | — | — | 38 | 1.68K | 205 | 88 | 84 | 67 | 65 | — | 6 | — | — | — | — | — |
| Citigroup Inc | — | 57 | 7.74K | 75 | 1.48K | — | — | — | — | — | — | — | — | — | — | — |
| Vanguard Group | — | — | — | 10.43K | 40.64K | 176.90K | 260.87K | 260.87K | 171.99K | 70.33K | 20.00K | 20.00K | — | — | — | — |
| Renaissance Technologies | — | — | — | — | — | — | — | — | 22.97K | 37.50K | — | — | — | — | — | — |
| Two Sigma Investments | — | — | — | — | — | — | — | — | — | — | 21.64K | 21.64K | 21.84K | 26.59K | — | — |
| Wells Fargo & Co | — | — | — | — | — | — | — | — | — | 45 | 41 | 38 | 36 | 34 | 27 | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details